These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17348121)

  • 21. Adjuvant taxanes: more to the story.
    Gajria D; Seidman A; Dang C
    Clin Breast Cancer; 2010 Sep; 10 Suppl 2():S41-9. PubMed ID: 20805064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study.
    Freyer G; Campone M; Peron J; Facchini T; Terret C; Berdah JF; Jacquin JP; Coeffic D; Hilaire Pde S; Falandry C
    Crit Rev Oncol Hematol; 2011 Dec; 80(3):466-73. PubMed ID: 21565521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two elderly patients with advanced breast cancer successfully treated by tri-weekly docetaxel].
    Okubo A; Hino N; Ikushima Y; Mori R; Amano S; Tsuyuguchi M; Sounaka Y; Wada D; Yamasaki S; Miyake H; Miyoshi T; Ikawa K; Ogata Y; Matsuoka H; Kawakita N; Mikami C
    Gan To Kagaku Ryoho; 2010 May; 37(5):911-4. PubMed ID: 20495327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant anthracyclines and taxanes: quantifying the costs of therapeutic advances in breast cancer.
    Morris PG; Bach PB
    Onkologie; 2009 Sep; 32(8-9):464-6. PubMed ID: 19745589
    [No Abstract]   [Full Text] [Related]  

  • 25. nab-paclitaxel: a novel formulation of taxane for treatment of breast cancer.
    Vishnu P; Roy V
    Womens Health (Lond); 2010 Jul; 6(4):495-506. PubMed ID: 20597612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?
    Pérez-García J; Cortés J
    Breast Cancer Res; 2012 Jan; 14(1):104. PubMed ID: 22297134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up).
    Icli F; Akbulut H; Onur H; Yalcin B; Demirkazık A; Senler FÇ
    Breast; 2011 Apr; 20(2):155-7. PubMed ID: 20951586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
    Kelly MP; Lee ST; Lee FT; Smyth FE; Davis ID; Brechbiel MW; Scott AM
    Prostate; 2009 Jan; 69(1):92-104. PubMed ID: 18942092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAXTOX - a retrospective study regarding the side effects of docetaxel given as part of the adjuvant treatment to patients with primary breast cancer in Denmark from 2007 to 2009.
    Eckhoff L; Nielsen M; Moeller S; Knoop A
    Acta Oncol; 2011 Oct; 50(7):1075-82. PubMed ID: 21824038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adjuvant chemotherapy with taxoid-containing drugs in breast cancer: soon to be expected in the Netherlands].
    Nortier JW
    Ned Tijdschr Geneeskd; 2004 Jul; 148(31):1524-8. PubMed ID: 15366720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.
    de Azambuja E; McCaskill-Stevens W; Francis P; Quinaux E; Crown JP; Vicente M; Giuliani R; Nordenskjöld B; Gutiérez J; Andersson M; Vila MM; Jakesz R; Demol J; Dewar J; Santoro A; Lluch A; Olsen S; Gelber RD; Di Leo A; Piccart-Gebhart M
    Breast Cancer Res Treat; 2010 Jan; 119(1):145-53. PubMed ID: 19731015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.
    Sonnenblick A; Francis PA; Azim HA; de Azambuja E; Nordenskjöld B; Gutiérez J; Quinaux E; Mastropasqua MG; Ameye L; Anderson M; Lluch A; Gnant M; Goldhirsch A; Di Leo A; Barnadas A; Cortes-Funes H; Piccart M; Crown J
    Eur J Cancer; 2015 Aug; 51(12):1481-9. PubMed ID: 26074397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adjuvant chemotherapy for breast cancer and targeted therapies].
    Dufresne A; Bachelot T; Blay JY
    Rev Prat; 2008 Mar; 58(5):477-8. PubMed ID: 18524101
    [No Abstract]   [Full Text] [Related]  

  • 34. Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancer.
    Ravdin PM
    Semin Oncol; 1999 Jun; 26(3 Suppl 9):20-3. PubMed ID: 10426455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients.
    Lévy P; Gligorov J; Antoine M; Rezai K; Lévy E; Selle F; Saintigny P; Lokiec F; Avenin D; Beerblock K; Lotz JP; Bernaudin JF; Fajac A
    Breast Cancer Res Treat; 2013 Jun; 139(2):421-8. PubMed ID: 23666532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The antitumor and radiosensitization effects of docetaxel on human hepatocellular carcinoma in vivo].
    Geng CX; Zeng ZC; Wang JY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):60-1. PubMed ID: 15670501
    [No Abstract]   [Full Text] [Related]  

  • 37. A Phase I Trial of 100 mg/m2 Docetaxel in Patients with Advanced or Recurrent Breast Cancer.
    Tamura T; Hirata T; Tabata M; Hinotsu S; Hamada A; Motoki T; Iwamoto T; Mizoo T; Nogami T; Shien T; Taira N; Matsuoka J; Doihara H
    Acta Med Okayama; 2016 Oct; 70(5):425-427. PubMed ID: 27777441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer].
    Fattoruso SI; Rossi S; Vici P; Di Filippo F; Botti C; Di Lauro L; Foggi P; Saracca E; Ferranti FR; Visca P; Lopez M
    Clin Ter; 2008; 159(6):443-7. PubMed ID: 19169606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions.
    Dang CT
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):427-36. PubMed ID: 16503859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic Effects of the Therapeutic Radionuclide Rhenium-188 Combined with Taxanes in Human Prostate Carcinoma Cell Lines.
    Lange R; ter Heine R; van Wieringen WN; Tromp AM; Paap M; Bloemendal HJ; de Klerk JM; Hendrikse NH; Geldof AA
    Cancer Biother Radiopharm; 2017 Feb; 32(1):16-23. PubMed ID: 28118029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.